LTBP2 regulates cisplatin resistance in GC cells via activation of the NF-κB2/BCL3 pathway

Abstract Gastric cancer (GC) often develops resistance to cisplatin treatment, but while latent transforming growth factor β-binding protein (LTBP2) is recognized as a potential regulator in GC, its specific role in cisplatin resistance is not fully understood. This study investigated LTBP2’s impact...

Full description

Bibliographic Details
Main Authors: Jun Wang, Wenjia Liang, Xiangwen Wang, Zhao Chen, Lei Jiang
Format: Article
Language:English
Published: Sociedade Brasileira de Genética 2024-04-01
Series:Genetics and Molecular Biology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572024000300101&tlng=en